Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Slipicevic

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|January 10, 2015
KIT in melanoma: many shades of grayAna Slipicevic, Meenhard Herlyn
Upsala Journal of Medical Sciences|February 21, 2012
Narrowing the knowledge gaps for melanomaAna Slipicevic, Meenhard Herlyn
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Isolation of melanoma cell subpopulations using negative selectionAna Slipicevic, Rajasekharan Somasundaram, Katrin Sproesser, et al.
Cancer Medicine|March 18, 2021
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapyMarina Juraleviciute, Jérémie Nsengimana, Julia Newton-Bishop, et al.
Hemasphere|June 17, 2021
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor CellsKonstantin Byrgazov, Andrej Besse, Marianne Kraus, et al.
Cancer Medicine|February 10, 2015
Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanomaVivi Ann Flørenes, Elisabeth Emilsen, Hiep Phuc Dong, et al.
Plos One|April 8, 2015
Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosisZhihui Wang, Ana Slipicevic, Mette Førsund, et al.
Leukemia Research|January 10, 2021
Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugsKonstantin Byrgazov, Marianne Kraus, Andrej Besse, et al.
Cancer Medicine|July 3, 2018
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitroZhihui Wang, Mette S Førsund, Claes G Trope, et al.
Histology and Histopathology|September 12, 2008
Fli-1 expression in malignant melanomaEmina E Torlakovic, Ana Slipicevic, Vivi Ann Flørenes, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|January 10, 2015
KIT in melanoma: many shades of grayAna Slipicevic, Meenhard Herlyn
Upsala Journal of Medical Sciences|February 21, 2012
Narrowing the knowledge gaps for melanomaAna Slipicevic, Meenhard Herlyn
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Isolation of melanoma cell subpopulations using negative selectionAna Slipicevic, Rajasekharan Somasundaram, Katrin Sproesser, et al.
Cancer Medicine|March 18, 2021
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapyMarina Juraleviciute, Jérémie Nsengimana, Julia Newton-Bishop, et al.
Hemasphere|June 17, 2021
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor CellsKonstantin Byrgazov, Andrej Besse, Marianne Kraus, et al.
Cancer Medicine|February 10, 2015
Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanomaVivi Ann Flørenes, Elisabeth Emilsen, Hiep Phuc Dong, et al.
Plos One|April 8, 2015
Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosisZhihui Wang, Ana Slipicevic, Mette Førsund, et al.
Leukemia Research|January 10, 2021
Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugsKonstantin Byrgazov, Marianne Kraus, Andrej Besse, et al.
Cancer Medicine|July 3, 2018
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitroZhihui Wang, Mette S Førsund, Claes G Trope, et al.
Histology and Histopathology|September 12, 2008
Fli-1 expression in malignant melanomaEmina E Torlakovic, Ana Slipicevic, Vivi Ann Flørenes, et al.
Pageof 4